← SynDRA

RUBITECAN

SynDRA canonical compound SYN0003304 — structure-anchored drug synonym record

All known targets

• TOP1

Mechanisms of action (all sources)

• TOP1 INHIBITOR
• DNA topoisomerase I inhibitor
• topoisomerase inhibitor

Drug classes

• Antineoplastic Agents
• Enzyme Inhibitors
• Topoisomerase I Inhibitors
• Topoisomerase Inhibitors

Cross-references

• PubChem CID: 472335
• ChEMBL: CHEMBL77305
• DrugBank: DB06159
• ChEBI: CHEBI:90225
• KEGG: D04031
• Wikipedia: Rubitecan
• TTD: D0Y1FO

Synonyms

• 9-Nitrocamptothecin
• orathecin
• 9-nc
• 9-nitro-20(s)-camptothecin
• 9-nitro-20-(s)-camptothecin
• 9-nitrocamptothecin
• RFS-2000
• RFS2000
• Orathecin
• 9-nitro-20(S)-camptothecin
• Camptogen
• 9-NC
• UNII-H19C446XXB
• Nitrocamptothecin
• H19C446XXB
• CHEBI:90225
• C20H15N3O6
• (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
• NCGC00167969-01
• (s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
• 9NC
• Q-100889
• (4s)-4-ethyl-4-hydroxy-10-nitro-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
• Inhaled Orathecin
• L9NC
• Rubitecan (inhaled)
• Aerosolized liposomal 9 nitro-20 (S) camptothecin
• Rubitecan (inhaled), SuperGen
• 9-Nitrocamptothecin (9-NC)
• 9-nitro-(20S)-camptothecin
• 9-nitro-20-(S)-camptothecin
• RFS 2000;9-Nitrocamptothecin
• 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-10-nitro-, (4S)-
• Rubitecan [USAN]
• Rubitecan [USAN:INN]
• rubitecanum
• 1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-
• 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-9-nitro-